Supriya Lifescience Ltd
NSE:SUPRIYA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Supriya Lifescience Ltd
NSE:SUPRIYA
|
IN |
|
Brunswick Corp
NYSE:BC
|
US |
|
CIELO SA Instituicao de Pagamento
F:28MA
|
BR |
|
Majestic Gold Corp
XTSX:MJS
|
CA |
|
Exide Industries Ltd
NSE:EXIDEIND
|
IN |
|
K
|
Kinross Gold Corp
XMUN:KIN2
|
CA |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
US |
|
Victoria Care Indonesia Tbk PT
IDX:VICI
|
ID |
|
A
|
Arribatec Group ASA
F:B7Z
|
NO |
|
Suntory Beverage & Food Ltd
TSE:2587
|
JP |
Wall St Price Targets
SUPRIYA Price Targets Summary
Supriya Lifescience Ltd
According to Wall Street analysts, the average 1-year price target for SUPRIYA is 867 INR with a low forecast of 858.5 INR and a high forecast of 892.5 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SUPRIYA's stock price target?
Price Target
867
INR
According to Wall Street analysts, the average 1-year price target for SUPRIYA is 867 INR with a low forecast of 858.5 INR and a high forecast of 892.5 INR.
What is the Revenue forecast for Supriya Lifescience Ltd?
Projected CAGR
27%
Over the last 7 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 2 years is 27%.
What is the Gross Profit forecast for Supriya Lifescience Ltd?
Projected CAGR
30%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 25%. The projected CAGR for the next 2 years is 30%.
What is the Operating Income forecast for Supriya Lifescience Ltd?
Projected CAGR
29%
Over the last 7 years, the compound annual growth rate for Operating Income has been 23%. The projected CAGR for the next 2 years is 29%.
What is the Pre-Tax Income forecast for Supriya Lifescience Ltd?
Projected CAGR
29%
Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 25%. The projected CAGR for the next 2 years is 29%.
What is the Net Income forecast for Supriya Lifescience Ltd?
Projected CAGR
27%
Over the last 7 years, the compound annual growth rate for Net Income has been 27%. The projected CAGR for the next 2 years is 27%.
